Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Bruni

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 20, 2023
Validation of RayStation Monte Carlo dose calculation algorithm for multiple LINACsLuigi Manco, Kevin Vega, Nicola Maffei, et al.
Tumori|October 28, 2009
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: a retrospective analysisLorenzo Livi, Icro Meattini, Carla De Luca Cardillo, et al.
Anti-Cancer Drugs|July 15, 2024
Complete and durable regression of leptomeningeal involvement during lorlatinib treatment in a patient with lung cancerGiorgia Guaitoli, Enrica Martinelli, Lucia Trudu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2025
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)Paolo Borghetti, Rolando D'Angelillo, Giorgio Facheris, et al.
Radiation Oncology (London, England)|July 16, 2022
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLCPaolo Borghetti, Jessica Imbrescia, Giulia Volpi, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment RadiomodulationFederico Iori, Alessio Bruni, Salvatore Cozzi, et al.
Tumori|June 26, 2015
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factorsMichela Buglione, Marta Maddalo, Ercole Mazzeo, et al.
International Journal of Molecular Sciences|November 11, 2022
Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-TGiorgia Guaitoli, Giovanni Neri, Eleonora Cabitza, et al.
La Radiologia Medica|October 29, 2018
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)-Lung Working GroupGiuseppe Parisi, Rosario Mazzola, Patrizia Ciammella, et al.
La Radiologia Medica|May 6, 2021
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Anna Merlotti, Alessio Bruni, Paolo Borghetti, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|April 20, 2023
Validation of RayStation Monte Carlo dose calculation algorithm for multiple LINACsLuigi Manco, Kevin Vega, Nicola Maffei, et al.
Tumori|October 28, 2009
Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: a retrospective analysisLorenzo Livi, Icro Meattini, Carla De Luca Cardillo, et al.
Anti-Cancer Drugs|July 15, 2024
Complete and durable regression of leptomeningeal involvement during lorlatinib treatment in a patient with lung cancerGiorgia Guaitoli, Enrica Martinelli, Lucia Trudu, et al.
Lung Cancer (Amsterdam, Netherlands)|November 5, 2025
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO)Paolo Borghetti, Rolando D'Angelillo, Giorgio Facheris, et al.
Radiation Oncology (London, England)|July 16, 2022
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLCPaolo Borghetti, Jessica Imbrescia, Giulia Volpi, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Can Radiotherapy Empower the Host Immune System to Counterattack Neoplastic Cells? A Systematic Review on Tumor Microenvironment RadiomodulationFederico Iori, Alessio Bruni, Salvatore Cozzi, et al.
Tumori|June 26, 2015
Reirradiation in head and neck recurrent or second primary tumor: efficacy, safety, and prognostic factorsMichela Buglione, Marta Maddalo, Ercole Mazzeo, et al.
International Journal of Molecular Sciences|November 11, 2022
Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-TGiorgia Guaitoli, Giovanni Neri, Eleonora Cabitza, et al.
La Radiologia Medica|October 29, 2018
Hypofractionated radiation therapy in the management of locally advanced NSCLC: a narrative review of the literature on behalf of the Italian Association of Radiation Oncology (AIRO)-Lung Working GroupGiuseppe Parisi, Rosario Mazzola, Patrizia Ciammella, et al.
La Radiologia Medica|May 6, 2021
Sequential chemo-hypofractionated RT versus concurrent standard CRT for locally advanced NSCLC: GRADE recommendation by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Anna Merlotti, Alessio Bruni, Paolo Borghetti, et al.
Pageof 8